Dr. Maria De Lourdes Garcia-Garcia - International Federation on Ageing. Mexico City, , MX

Dr. Maria De Lourdes Garcia-Garcia Dr. Maria De Lourdes Garcia-Garcia

Deputy Director | Centre for Resrach on Infectious Disease (Instituto Nacional de Salud Publica)

Mexico City, MX
Dr. Garcia-Garcia has been interested in research in infectious diseases particularly tuberculosis and vaccine preventable diseases

Spotlight

Biography

Dr. Garcia-Garcia is an advisor for the Working Group for Clinical Care of the National Plan of Preparation and Response to the Influenza Pandemic of the Secretariat of Health, the National Survey of Tuberculosis Drug Resistance of the Secretariat of Health and the Mexican section of the Committee Stop TB. She reviews articles from several journals such as PLOS, Diabetes Care, Tuberculosis, Clinical Infectious Diseases, among others.
Dr. Garcia-Garcia has been interested in research in infectious diseases particularly tuberculosis and vaccine preventable diseases. In 2015 she co-authored a book on Vaccines for the Ageing Population published by the Mexican Academy of Medicine.
She has published more than 100 research articles, 5 books, and 44 book chapters. She has taught several courses at postgraduate level and directed 23 Specialty, Masters and Doctoral theses at the National Institute of Public Health since 1995 to present.

Industry Expertise (1)

Research

Areas of Expertise (4)

Adult Vaccination Infectious Diseases Influenza Tuberculosis

Languages (1)

  • English

Featured Articles (4)

Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children
Vaccine

2006

Aerosol measles vaccination has been found to be more immunogenic than subcutaneous administration as a booster in school aged children, and immunogenic in 12-month-old children as a primary dose. The objective of the study was to evaluate immunogenicity to aerosol measles vaccine in 9-month-old children.

view more


Induction of Cellular and Humoral Immunity after Aerosol or Subcutaneous Administration of Edmonston-Zagreb Measles Vaccine as a Primary Dose to 12-Month-Old Children
The Journal of Infectious Diseases

2004

Infants were immunized by aerosol (103.6 plaque-forming units [pfu]/dose) or subcutaneous (sc) (104.27 pfu/dose) administration of Edmonston-Zagreb measles vaccine. Measles-specific T cell proliferative responses with a stimulation index of ⩾3 developed in 72% of children given aerosol-administered vaccine, compared with 87% given sc-administered vaccine (P = .06)...

view more


Factors associated with tuberculin reactivity in two general hospitals in Mexico
Infection Control and Hospital Epidemiology

2001

OBJECTIVE. To identify risk factors associated with tuberculin reactivity in healthcare workers (HCWs)...

view more


Clinical Consequences and Transmissibility of Drug-Resistant Tuberculosis in Southern Mexico
JAMA Internal Medicine

2000

A prospective cohort and molecular epidemiologic study was conducted in southern Mexico. Between March 1995 and February 1998 all patients with persistent cough whose sputa had acid-fast bacilli (AFB) underwent clinical and mycobacteriologic evaluation (species identification, drug susceptibility testing, and IS6110-based genotyping). Treatment was provided in accordance with Mexico's National Tuberculosis Program...

view more


Contact Dr. Maria De Lourdes Garcia-Garcia